CN Stock MarketDetailed Quotes

300630 Hainan Poly Pharm

Watchlist

10.56
+0.31+3.02%

Market Closed Nov 19 15:00 CST

4.77BMarket Cap-44936P/E (TTM)

Hainan Poly Pharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hainan Poly Pharm Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2023/FY	1.304B / 2.051B	--
--	2022/FY	1.806B / 1.983B	--
--	2021/FY	1.509B / 1.693B	--
--	2020/FY	1.189B / 1.223B	--
--	2019/FY	950.095M / 1.100B	--

DatePeriodRevenue/EstimateEarnings Call

--2023/FY1.304B / 2.051B--

--2022/FY1.806B / 1.983B--

--2021/FY1.509B / 1.693B--

--2020/FY1.189B / 1.223B--

--2019/FY950.095M / 1.100B--

Unlock Free Earnings Estimates

Open Account

Hainan Poly Pharm Earnings Reports

Puli Pharmaceuticals: Third Quarter Report 2024 (after correction)

Nov 4 06:42 ET

Puli Pharmaceuticals: Corrections to the 2024 Third Quarter Report

Nov 4 06:42 ET

Puli Pharmaceuticals: Report for the third quarter of 2024

Oct 27 12:00 ET

Puli Pharmaceuticals: Semi-Annual Report 2024

Aug 28 12:00 ET

Analyst Rating

Updated: Nov 19, 2024

Buy

Strong Buy
33.33%
Buy
66.67%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall